Serveur d'exploration COVID et hydrochloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Advance of promising targets and agents against COVID-19 in China.

Identifieur interne : 001A56 ( Main/Curation ); précédent : 001A55; suivant : 001A57

Advance of promising targets and agents against COVID-19 in China.

Auteurs : Yongtao Duan [République populaire de Chine] ; Hai-Liang Zhu [République populaire de Chine] ; Chongchen Zhou [République populaire de Chine]

Source :

RBID : pubmed:32198066

Descripteurs français

English descriptors


DOI: 10.1016/j.drudis.2020.02.011
PubMed: 32198066
PubMed Central: PMC7102657

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:32198066

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Advance of promising targets and agents against COVID-19 in China.</title>
<author>
<name sortKey="Duan, Yongtao" sort="Duan, Yongtao" uniqKey="Duan Y" first="Yongtao" last="Duan">Yongtao Duan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Zhu, Hai Liang" sort="Zhu, Hai Liang" uniqKey="Zhu H" first="Hai-Liang" last="Zhu">Hai-Liang Zhu</name>
<affiliation wicri:level="1">
<nlm:affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, China. Electronic address: zhuhl@nju.edu.cn.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Zhou, Chongchen" sort="Zhou, Chongchen" uniqKey="Zhou C" first="Chongchen" last="Zhou">Chongchen Zhou</name>
<affiliation wicri:level="1">
<nlm:affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. Electronic address: zhouchongchen@163.com.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32198066</idno>
<idno type="pmid">32198066</idno>
<idno type="doi">10.1016/j.drudis.2020.02.011</idno>
<idno type="pmc">PMC7102657</idno>
<idno type="wicri:Area/Main/Corpus">001A56</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001A56</idno>
<idno type="wicri:Area/Main/Curation">001A56</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001A56</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Advance of promising targets and agents against COVID-19 in China.</title>
<author>
<name sortKey="Duan, Yongtao" sort="Duan, Yongtao" uniqKey="Duan Y" first="Yongtao" last="Duan">Yongtao Duan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Zhu, Hai Liang" sort="Zhu, Hai Liang" uniqKey="Zhu H" first="Hai-Liang" last="Zhu">Hai-Liang Zhu</name>
<affiliation wicri:level="1">
<nlm:affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, China. Electronic address: zhuhl@nju.edu.cn.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Zhou, Chongchen" sort="Zhou, Chongchen" uniqKey="Zhou C" first="Chongchen" last="Zhou">Chongchen Zhou</name>
<affiliation wicri:level="1">
<nlm:affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. Electronic address: zhouchongchen@163.com.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Drug discovery today</title>
<idno type="eISSN">1878-5832</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adenine (analogs & derivatives)</term>
<term>Adenine (therapeutic use)</term>
<term>Adenosine Monophosphate (analogs & derivatives)</term>
<term>Adenosine Monophosphate (therapeutic use)</term>
<term>Alanine (analogs & derivatives)</term>
<term>Alanine (therapeutic use)</term>
<term>Amides (therapeutic use)</term>
<term>Antimalarials (therapeutic use)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Betacoronavirus (metabolism)</term>
<term>COVID-19 (MeSH)</term>
<term>China (MeSH)</term>
<term>Chloroquine (therapeutic use)</term>
<term>Clinical Trials as Topic (MeSH)</term>
<term>Cobicistat (therapeutic use)</term>
<term>Coronavirus 3C Proteases (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Cysteine Endopeptidases (metabolism)</term>
<term>Dibenzothiepins (MeSH)</term>
<term>Drug Combinations (MeSH)</term>
<term>Drug Discovery (MeSH)</term>
<term>Drug Therapy, Combination (MeSH)</term>
<term>Emtricitabine (therapeutic use)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Indoles (therapeutic use)</term>
<term>Lopinavir (therapeutic use)</term>
<term>Medicine, Chinese Traditional (MeSH)</term>
<term>Morpholines (MeSH)</term>
<term>Oseltamivir (therapeutic use)</term>
<term>Oxazines (therapeutic use)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pyrazines (therapeutic use)</term>
<term>Pyridines (therapeutic use)</term>
<term>Pyridones (MeSH)</term>
<term>RNA-Dependent RNA Polymerase (metabolism)</term>
<term>Ritonavir (therapeutic use)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Spike Glycoprotein, Coronavirus (metabolism)</term>
<term>Tenofovir (therapeutic use)</term>
<term>Thiepins (therapeutic use)</term>
<term>Triazines (therapeutic use)</term>
<term>Viral Nonstructural Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>AMP (analogues et dérivés)</term>
<term>AMP (usage thérapeutique)</term>
<term>Adénine (analogues et dérivés)</term>
<term>Adénine (usage thérapeutique)</term>
<term>Alanine (analogues et dérivés)</term>
<term>Alanine (usage thérapeutique)</term>
<term>Amides (usage thérapeutique)</term>
<term>Antipaludiques (usage thérapeutique)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Association de médicaments (MeSH)</term>
<term>Association médicamenteuse (MeSH)</term>
<term>Betacoronavirus (métabolisme)</term>
<term>Chine (MeSH)</term>
<term>Chloroquine (usage thérapeutique)</term>
<term>Cobicistat (usage thérapeutique)</term>
<term>Cysteine endopeptidases (métabolisme)</term>
<term>Dibenzothiépines (MeSH)</term>
<term>Découverte de médicament (MeSH)</term>
<term>Emtricitabine (usage thérapeutique)</term>
<term>Essais cliniques comme sujet (MeSH)</term>
<term>Glycoprotéine de spicule des coronavirus (métabolisme)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Indoles (usage thérapeutique)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Lopinavir (usage thérapeutique)</term>
<term>Morpholines (MeSH)</term>
<term>Médecine traditionnelle chinoise (MeSH)</term>
<term>Oséltamivir (usage thérapeutique)</term>
<term>Oxazines (usage thérapeutique)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Protéines virales non structurales (métabolisme)</term>
<term>Pyrazines (usage thérapeutique)</term>
<term>Pyridines (usage thérapeutique)</term>
<term>Pyridones (MeSH)</term>
<term>Ritonavir (usage thérapeutique)</term>
<term>Thiépines (usage thérapeutique)</term>
<term>Triazines (usage thérapeutique)</term>
<term>Ténofovir (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Adenine</term>
<term>Adenosine Monophosphate</term>
<term>Alanine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Cysteine Endopeptidases</term>
<term>RNA-Dependent RNA Polymerase</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Viral Nonstructural Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Adenine</term>
<term>Adenosine Monophosphate</term>
<term>Alanine</term>
<term>Amides</term>
<term>Antimalarials</term>
<term>Antiviral Agents</term>
<term>Chloroquine</term>
<term>Cobicistat</term>
<term>Emtricitabine</term>
<term>Hydroxychloroquine</term>
<term>Indoles</term>
<term>Lopinavir</term>
<term>Oseltamivir</term>
<term>Oxazines</term>
<term>Pyrazines</term>
<term>Pyridines</term>
<term>Ritonavir</term>
<term>Tenofovir</term>
<term>Thiepins</term>
<term>Triazines</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>China</term>
<term>Coronavirus 3C Proteases</term>
<term>Dibenzothiepins</term>
<term>Drug Combinations</term>
<term>Morpholines</term>
<term>Pyridones</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr">
<term>AMP</term>
<term>Adénine</term>
<term>Alanine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Betacoronavirus</term>
<term>Cysteine endopeptidases</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Protéines virales non structurales</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>AMP</term>
<term>Adénine</term>
<term>Alanine</term>
<term>Amides</term>
<term>Antipaludiques</term>
<term>Antiviraux</term>
<term>Chloroquine</term>
<term>Cobicistat</term>
<term>Emtricitabine</term>
<term>Hydroxychloroquine</term>
<term>Indoles</term>
<term>Lopinavir</term>
<term>Oséltamivir</term>
<term>Oxazines</term>
<term>Pyrazines</term>
<term>Pyridines</term>
<term>Ritonavir</term>
<term>Thiépines</term>
<term>Triazines</term>
<term>Ténofovir</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>COVID-19</term>
<term>Clinical Trials as Topic</term>
<term>Drug Discovery</term>
<term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Medicine, Chinese Traditional</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Association de médicaments</term>
<term>Association médicamenteuse</term>
<term>Chine</term>
<term>Dibenzothiépines</term>
<term>Découverte de médicament</term>
<term>Essais cliniques comme sujet</term>
<term>Humains</term>
<term>Morpholines</term>
<term>Médecine traditionnelle chinoise</term>
<term>Pandémies</term>
<term>Pyridones</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>République populaire de Chine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32198066</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>06</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-5832</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>25</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2020</Year>
<Month>05</Month>
</PubDate>
</JournalIssue>
<Title>Drug discovery today</Title>
<ISOAbbreviation>Drug Discov Today</ISOAbbreviation>
</Journal>
<ArticleTitle>Advance of promising targets and agents against COVID-19 in China.</ArticleTitle>
<Pagination>
<MedlinePgn>810-812</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1359-6446(20)30098-2</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.drudis.2020.02.011</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Duan</LastName>
<ForeName>Yongtao</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhu</LastName>
<ForeName>Hai-Liang</ForeName>
<Initials>HL</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, China. Electronic address: zhuhl@nju.edu.cn.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Chongchen</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. Electronic address: zhouchongchen@163.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016421">Editorial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>03</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Drug Discov Today</MedlineTA>
<NlmUniqueID>9604391</NlmUniqueID>
<ISSNLinking>1359-6446</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000577">Amides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003988">Dibenzothiepins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007211">Indoles</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009025">Morpholines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010078">Oxazines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011719">Pyrazines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011725">Pyridines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011728">Pyridones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013846">Thiepins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014227">Triazines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000613801">emtricitabine tenofovir alafenamide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C558899">lopinavir-ritonavir drug combination</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>20O93L6F9H</RegistryNumber>
<NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>2494G1JF75</RegistryNumber>
<NameOfSubstance UI="D061466">Lopinavir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>3QKI37EEHE</RegistryNumber>
<NameOfSubstance UI="C000606551">remdesivir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>415SHH325A</RegistryNumber>
<NameOfSubstance UI="D000249">Adenosine Monophosphate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>4G86Y4JT3F</RegistryNumber>
<NameOfSubstance UI="C000628402">baloxavir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>93M09WW4RU</RegistryNumber>
<NameOfSubstance UI="C086979">umifenovir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>99YXE507IL</RegistryNumber>
<NameOfSubstance UI="D000068698">Tenofovir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.7.48</RegistryNumber>
<NameOfSubstance UI="D012324">RNA-Dependent RNA Polymerase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.22.-</RegistryNumber>
<NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.22.28</RegistryNumber>
<NameOfSubstance UI="D000086782">Coronavirus 3C Proteases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EW5GL2X7E0</RegistryNumber>
<NameOfSubstance UI="C462182">favipiravir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>G70B4ETF4S</RegistryNumber>
<NameOfSubstance UI="D000068679">Emtricitabine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>JAC85A2161</RegistryNumber>
<NameOfSubstance UI="D000225">Adenine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>LW2E03M5PG</RegistryNumber>
<NameOfSubstance UI="D000069547">Cobicistat</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>O3J8G9O825</RegistryNumber>
<NameOfSubstance UI="D019438">Ritonavir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>OF5P57N2ZX</RegistryNumber>
<NameOfSubstance UI="D000409">Alanine</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000225" MajorTopicYN="N">Adenine</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000249" MajorTopicYN="N">Adenosine Monophosphate</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000409" MajorTopicYN="N">Alanine</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000577" MajorTopicYN="N">Amides</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000069547" MajorTopicYN="N">Cobicistat</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086782" MajorTopicYN="N">Coronavirus 3C Proteases</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003988" MajorTopicYN="N">Dibenzothiepins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000068679" MajorTopicYN="N">Emtricitabine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007211" MajorTopicYN="N">Indoles</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D061466" MajorTopicYN="N">Lopinavir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008516" MajorTopicYN="N">Medicine, Chinese Traditional</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009025" MajorTopicYN="N">Morpholines</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010078" MajorTopicYN="N">Oxazines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011719" MajorTopicYN="N">Pyrazines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011725" MajorTopicYN="N">Pyridines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011728" MajorTopicYN="N">Pyridones</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012324" MajorTopicYN="N">RNA-Dependent RNA Polymerase</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019438" MajorTopicYN="N">Ritonavir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000068698" MajorTopicYN="N">Tenofovir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013846" MajorTopicYN="N">Thiepins</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014227" MajorTopicYN="N">Triazines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>02</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>02</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32198066</ArticleId>
<ArticleId IdType="pii">S1359-6446(20)30098-2</ArticleId>
<ArticleId IdType="doi">10.1016/j.drudis.2020.02.011</ArticleId>
<ArticleId IdType="pmc">PMC7102657</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32075877</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32007145</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2020 Feb 19;368:m606</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32075786</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2020 Mar 27;367(6485):1444-1448</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32132184</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A56 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001A56 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:32198066
   |texte=   Advance of promising targets and agents against COVID-19 in China.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i   -Sk "pubmed:32198066" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021